Pressurized metered-dose inhalers (pMDIs) for COPD and asthma contribute to climate change, and countries are moving away from their use.

Ohtuvayre is the first new inhaled COPD therapy approved in over two decades. COPD is a chronic inflammatory condition that ...

The global aerosol delivery devices market was valued at $31,463.9 million in 2019, and is projected to reach $46,728.7 million by 2027, registering a CAGR of 4.9% from 2020 to 2027. Rise in ...

With Medicare coverage, a person can still have certain out-of-pocket costs for an inhaler. Out-of-pocket cost: This is the amount a person must pay for care when Medicare does not pay the total ...

But the clinical trials of these medications specifically excluded people with type 1 diabetes, who are dependent on the hormone insulin to survive because they can’t make enough of their own ...

Patricia Mikula, PharmD, has over nine years of experience and works as an inpatient clinical pharmacist for medical/surgical and intensive care unit patients. She also oversees a hospital-based ...

GEORGE COUNTY, Miss. (WKRG) — The George County Sheriff’s Office is holding an event for National Drug Enforcement Administration Drug Takeback Day. According to GCSO officials, deputies will ...

So, more recently, the guidelines have said, you know, we have our inhalers for asthma ... now that weren't before are things like biologic medications. And so, these are injections most ...

One of the most consumed drugs in the US – and the most commonly taken analgesic worldwide – may do a lot more than simply take the edge off your headache. Acetaminophen, also known as paracetamol and ...

People who take regular medication for a range of health conditions may not be aware that certain fruits, vegetables, dairy products, and drinks can interact with the medicine and stop it from ...

White House just joined that list with a Ghibli-esque meme of convicted drug dealer Virginia Basora-Gonzalez, who was detained by US Immigration and Customs Enforcement (ICE). The post has taken ...

The European Medicines Agency has rejected Lilly’s Alzheimer’s drug Kisunla for a license, saying its benefits don’t outweigh the risk of brain swelling or bleeding. The treatment for early ...